Introduction: The subcutaneous implantable cardioverter defibrillator (S-ICD) is currently in its third generation and has been adopted in guidelines and in mainstream clinical practice. Considerable improvements have been made since the introduction of this device over a decade ago.
Areas covered: A literature search was undertaken in Pubmed on articles relating to the S-ICD.
Expert opinion: The therapy has been proven to be safe and effective and is a valuable option in selected patients. Nevertheless, there remain many shortcomings of the S-ICD which are discussed in this review, and which hopefully will be addressed by future generations of the device.
Keywords: CIED; S-ICD; Subcutaneous implantable cardioverter defibrillator; cardiac implantable electronic device; implantable cardioverter defibrillator.